5JGD
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 12 | 分子名称: | N-(2-isopropoxy-3-(4-methylpiperazine-1-carbonyl)phenyl)-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxamide, TAK1 kinase - TAB1 chimera fusion protein | 著者 | Irie, M, Nakamura, M, Fukami, T.A, Matsuura, T, Morishima, K. | 登録日 | 2016-04-20 | 公開日 | 2016-07-27 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (3.101 Å) | 主引用文献 | Discovery of a potent and highly selective transforming growth factor beta receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD) Bioorg.Med.Chem., 24, 2016
|
|
5JGA
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 11c | 分子名称: | N-[5-(4-methylpiperazine-1-carbonyl)[1,1'-biphenyl]-2-yl]-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxamide, TAK1 kinase - TAB1 chimera fusion protein | 著者 | Irie, M, Nakamura, M, Fukami, T.A, Matsuura, T, Morishima, K. | 登録日 | 2016-04-19 | 公開日 | 2016-07-27 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Discovery of a potent and highly selective transforming growth factor beta receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD) Bioorg.Med.Chem., 24, 2016
|
|
3RCD
| HER2 Kinase Domain Complexed with TAK-285 | 分子名称: | N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide, Receptor tyrosine-protein kinase erbB-2 | 著者 | Aertgeerts, K, Skene, R, Sogabe, S. | 登録日 | 2011-03-30 | 公開日 | 2011-11-23 | 最終更新日 | 2023-09-13 | 実験手法 | X-RAY DIFFRACTION (3.21 Å) | 主引用文献 | Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold. J.Med.Chem., 54, 2011
|
|
3APC
| Crystal structure of human PI3K-gamma in complex with CH5132799 | 分子名称: | 5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, SULFATE ION | 著者 | Nakamura, M, Fukami, T.A, Miyazaki, T, Yoshida, M. | 登録日 | 2010-10-14 | 公開日 | 2011-04-13 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (2.544 Å) | 主引用文献 | Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799 Bioorg.Med.Chem.Lett., 21, 2011
|
|
3APD
| Crystal structure of human PI3K-gamma in complex with CH5108134 | 分子名称: | 5-(2-Morpholin-4-yl-7-pyridin-3-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, SULFATE ION | 著者 | Nakamura, M, Fukami, T.A, Miyazaki, T, Yoshida, M. | 登録日 | 2010-10-14 | 公開日 | 2011-04-13 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (2.55 Å) | 主引用文献 | Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799 Bioorg.Med.Chem.Lett., 21, 2011
|
|
6LZ9
| |
1GTW
| |
1GU4
| |
1GU5
| |
7WBT
| Crystal structure of bovine NLRP9 | 分子名称: | ADENOSINE-5'-DIPHOSPHATE, NACHT, LRR and PYD domains-containing protein 9 | 著者 | Kamitsukasa, Y, Shimizu, T, Ohto, U. | 登録日 | 2021-12-17 | 公開日 | 2022-04-06 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.75 Å) | 主引用文献 | The structure of NLRP9 reveals a unique C-terminal region with putative regulatory function. Febs Lett., 596, 2022
|
|
7WBU
| Cryo-EM structure of bovine NLRP9 | 分子名称: | ADENOSINE-5'-DIPHOSPHATE, NACHT, LRR and PYD domains-containing protein 9 | 著者 | Kamitsukasa, Y, Shimizu, T, Ohto, U. | 登録日 | 2021-12-17 | 公開日 | 2022-04-06 | 最終更新日 | 2024-06-26 | 実験手法 | ELECTRON MICROSCOPY (3.42 Å) | 主引用文献 | The structure of NLRP9 reveals a unique C-terminal region with putative regulatory function. Febs Lett., 596, 2022
|
|
5XCR
| |
5XCX
| Crystal structure of TS2/16 Fv-clasp fragment | 分子名称: | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID, GLYCEROL, PHOSPHATE ION, ... | 著者 | Arimori, T, Takagi, J. | 登録日 | 2017-03-23 | 公開日 | 2017-10-04 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.04 Å) | 主引用文献 | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCS
| Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide | 分子名称: | HA peptide, SULFATE ION, VH-SARAH(Y35C) chimera, ... | 著者 | Arimori, T, Takagi, J. | 登録日 | 2017-03-23 | 公開日 | 2017-10-04 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCQ
| Crystal structure of P20.1 Fv-clasp fragment with its antigen peptide | 分子名称: | C8 peptide, SULFATE ION, VH-SARAH(Y35C)chimera, ... | 著者 | Arimori, T, Takagi, J. | 登録日 | 2017-03-23 | 公開日 | 2017-10-04 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.313 Å) | 主引用文献 | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCU
| Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide | 分子名称: | HA peptide, SULFATE ION, VH(S112C)-SARAH chimera,VH(S112C)-SARAH chimera, ... | 著者 | Arimori, T, Takagi, J. | 登録日 | 2017-03-23 | 公開日 | 2017-10-04 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (2.454 Å) | 主引用文献 | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCV
| Crystal structure of NZ-1 Fv-clasp fragment with its antigen peptide | 分子名称: | CALCIUM ION, PA14 peptide, VH(S112C)-SARAH chimera,VH(S112C)-SARAH chimera, ... | 著者 | Arimori, T, Takagi, J. | 登録日 | 2017-03-23 | 公開日 | 2017-10-11 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.143 Å) | 主引用文献 | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5GJF
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 3 | 分子名称: | N-(2-isopropoxy-4-(4-methylpiperazine-1-carbonyl)phenyl)-2-(3-(3-phenylureido)phenyl)thiazole-4-carboxamide, TAK1 kinase - TAB1 chimera fusion protein | 著者 | Irie, M, Nakamura, M, Fukami, T.A, Matsuura, T, Morishima, K. | 登録日 | 2016-06-29 | 公開日 | 2016-11-16 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.89 Å) | 主引用文献 | Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD) Chem.Pharm.Bull., 64, 2016
|
|
5GJG
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 4 | 分子名称: | N-(2-isopropoxy-4-(4-methylpiperazine-1-carbonyl)phenyl)-2-(3-(phenylcarbamoyl)phenyl)thiazole-4-carboxamide, TAK1 kinase - TAB1 chimera fusion protein | 著者 | Irie, M, Nakamura, M, Fukami, T.A, Matsuura, T, Morishima, K. | 登録日 | 2016-06-29 | 公開日 | 2016-11-16 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (2.61 Å) | 主引用文献 | Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD) Chem.Pharm.Bull., 64, 2016
|
|
5GJD
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 2 | 分子名称: | 1-(4-((1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-3-(5-(4-methylpiperazin-1-yl)naphthalen-2-yl)urea, TAK1 kinase - TAB1 chimera fusion protein | 著者 | Irie, M, Nakamura, M, Fukami, T.A, Matsuura, T, Morishima, K. | 登録日 | 2016-06-29 | 公開日 | 2016-11-16 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (2.79 Å) | 主引用文献 | Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD) Chem.Pharm.Bull., 64, 2016
|
|
6L8A
| |
4YUU
| Crystal structure of oxygen-evolving photosystem II from a red alga | 分子名称: | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL, 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE, 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE, ... | 著者 | Ago, H, Shen, J.-R. | 登録日 | 2015-03-19 | 公開日 | 2016-01-20 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.7700038 Å) | 主引用文献 | Novel Features of Eukaryotic Photosystem II Revealed by Its Crystal Structure Analysis from a Red Alga J.Biol.Chem., 291, 2016
|
|
4PK6
| Crystal structure of the indoleamine 2,3-dioxygenagse 1 (IDO1) complexed with imidazothiazole derivative | 分子名称: | Indoleamine 2,3-dioxygenase 1, N-[2-(3-chlorophenyl)ethyl]-3-(4-methylphenyl)imidazo[2,1-b][1,3]thiazole-5-carboxamide, PROTOPORPHYRIN IX CONTAINING FE | 著者 | Kohno, T, Tojo, S, Ishii, T, Kamioka, S. | 登録日 | 2014-05-13 | 公開日 | 2014-09-03 | 最終更新日 | 2017-10-04 | 実験手法 | X-RAY DIFFRACTION (3.45 Å) | 主引用文献 | Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors. Acs Med.Chem.Lett., 5, 2014
|
|
5V2C
| RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX | 分子名称: | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL, 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE, 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE, ... | 著者 | Wang, J, Wiwczar, J.M, Brudvig, G.W. | 登録日 | 2017-03-03 | 公開日 | 2017-08-30 | 最終更新日 | 2023-10-04 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Chlorophyll a with a farnesyl tail in thermophilic cyanobacteria. Photosyn. Res., 134, 2017
|
|
5B7V
| Human FGFR1 kinase in complex with CH5183284 | 分子名称: | Fibroblast growth factor receptor 1, SULFATE ION, [5-amino-1-(2-methyl-1H-benzimidazol-6-yl)-1H-pyrazol-4-yl](1H-indol-2-yl)methanone | 著者 | Fukami, T.A, Lukacs, C.M, Janson, C. | 登録日 | 2016-06-09 | 公開日 | 2016-06-22 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (2.15 Å) | 主引用文献 | The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor Mol.Cancer Ther., 13, 2014
|
|